FDA-Drug2024-09-11Class II
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
ProRx LLC
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide in the USA
Affected count
37 vials
Manufactured in
619 Jeffers Cir, Exton, PA, United States
Products
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0651-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief